The differentially analysis indicated high expression of LINC00494 and low expression of FBXO32 in ovarian cancer, which was entirely consistent with corresponding findings in clinical cancer tissues and normal tissues (Figure 1A). This evidence concerns the gene LINC00494 and ovarian carcinoma.